Physician profile
Nikolaus Hjelm
NPI 1942610761
$4,186.70
in general payments reported to CMS, 2019-2025
24 companies · $1,233 in 2025
The $1,233 reported for 2025 was more than what 89% of Facial Plastic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $814 · 2022: $918 · 2023: $564 · 2024: $657 · 2025: $1,233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,400 · Education: $54.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,399.54 |
| Education | $54.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,403.43 | 2021-2025 | Inspire |
| Genzyme Corporation | $779.51 | 2021-2025 | |
| Glaxosmithkline, LLC. | $458.88 | 2021-2025 | Nucala |
| Exelixis INC. | $236.02 | 2022 | |
| Stryker Corporation | $197.21 | 2022-2025 | Audion Et Dilation System, Nasopore |
| Regeneron Healthcare Solutions, INC. | $194.00 | 2022-2025 | Dupixent |
| Hologic Sales and Service, LLC | $171.02 | 2024-2025 | Coolseal Generator |
| Optinose US, INC. | $145.66 | 2021-2025 | |
| Abbott Laboratories | $111.69 | 2022 | |
| Cochlear Americas | $80.55 | 2022-2024 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Sanofi-Aventis U.S. LLC | $54.95 | 2024 | |
| Smith+Nephew, INC. | $45.11 | 2021 | |
| Jazz Pharmaceuticals INC. | $43.17 | 2021 | |
| Lilly USA, LLC | $35.02 | 2025 | Zepbound |
| Phadia US INC. | $32.02 | 2021-2025 | Immunocap |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $29.22 | 2021-2023 | |
| Kaleo, INC. | $27.88 | 2022 | |
| Alk-Abello, INC | $26.75 | 2021 | |
| Intersect Ent, INC. | $24.36 | 2021-2022 | |
| Integra Lifesciences Corporation | $23.79 | 2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Ars Pharmaceuticals Operations, INC. | $19.55 | 2025 | Neffy |
| Avadel Cns Pharmaceuticals, LLC | $17.00 | 2024 | Lumryz |
| Paratek Pharmaceuticals, INC. | $15.21 | 2025 | Xhance |
| Aerin Medical INC. | $14.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikolaus Hjelm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.